Home » Clinical Trials » Medical Areas
Therapeutic Areas: Endocrinology | Neurology
Disease Category: Diabetic Neuropathy
Trial Information
Together we can fight DIABETIC NEUROPATHY PAIN.
If you're a diabetic who's experiencing tingling or burning foot pain, you can participate in a research study to evaluate an investigational pain medication that is unique in how it affects pain.
Local doctors are now evaluating an investigational pain medication to help treat foot pain associated with diabetes.
All qualified participants will receive study-related treatment and the investigational pain medication at no cost. Reimbursement for time and travel may also be provided.
Additionally, all participants who complete this study will recieve access to this novel, investigational pain medication for one full year.
To pre-qualify for this research study, a person must:
- Be 18 years or older
- Have a medical diagnosis of type-I (insulin dependent) or type-II (non-insulin dependent) diabetes
- Be experiencing pain due to chronic diabetic neuropathy for at least 6 months, with the primary pain location in the feet.
Patient Exclusion Criteria: please see inclusion
Tara Shepard, Clinical Research Coordinator
Clinical Research of West Florida, Inc.
5115 North Armenia Avenue
Tampa FL 33603
Phone: 813-870-1292 ext 226
Fax: 813-870-1252
EMail: tshepard@crwf.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.